Aug 8
|
Xeris Biopharma Reports Second Quarter 2023 Financial Results
|
Mar 30
|
Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™
|
Mar 29
|
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
|